Journal of Cell Biology and Metabolism

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Perspective - Journal of Cell Biology and Metabolism (2024) Volume 6, Issue 6

The Impact of Metabolic Dysfunction on Aging: Mechanisms and Therapeutic Targets

Ahmed Al-Farsi*

Faculty of Medicine, King Saud University, Saudi Arabia.

*Corresponding Author:
Ahmed Al-Farsi
Faculty of Medicine
King Saud University, Saudi Arabia.
E-mail: ahmed.alfarsi@ksu.edu.sa

Received: 03-Dec-2024, Manuscript No. AACBM-24-149375; Editor assigned: 04-Dec-2024, PreQC No. AACBM-24-1493755(PQ); Reviewed: 18-Dec-2024, QC No AACBM-24-1493755; Revised: 21-Dec-2024, Manuscript No. AACBM-24-1493755(R); Published: 28-Dec-2024, DOI:10.35841/aacbm-6.6.243

Citation: Al-Farsi A. The impact of metabolic dysfunction on aging: Mechanisms and therapeutic targets. J Cell Biol Metab. 2024;6(6):243.

Visit for more related articles at Journal of Cell Biology and Metabolism

Abstract

  

Introduction

Metabolic dysfunction plays a significant role in the aging process, contributing to a range of age-related diseases and conditions. As individuals age, the efficiency of metabolic pathways declines, leading to an accumulation of cellular damage, inflammation, and oxidative stress. These factors are key drivers of aging and are involved in the onset of numerous age-related conditions, including cardiovascular disease, type 2 diabetes, neurodegeneration, and frailty. Understanding the mechanisms underlying metabolic dysfunction and identifying potential therapeutic targets could provide insights into delaying the aging process and improving the quality of life in older adults [1].

Aging is often accompanied by a decline in the ability to regulate energy balance, which can manifest as insulin resistance, altered lipid metabolism, and mitochondrial dysfunction. Insulin resistance, in particular, is a hallmark of aging and has been linked to the development of age-related diseases like type 2 diabetes and cardiovascular disease. The decline in insulin sensitivity is partially due to the chronic low-grade inflammation that accumulates over time, disrupting the normal function of insulin signaling pathways. This persistent inflammatory state, often referred to as "inflammaging," is a central feature of metabolic dysfunction in aging [2].

Mitochondrial dysfunction is another critical factor in age-related metabolic changes. Mitochondria are essential for energy production, and their decline in function is associated with decreased cellular energy availability, increased production of reactive oxygen species (ROS), and impaired cellular repair mechanisms. These changes contribute to cellular aging and tissue degeneration. Additionally, the accumulation of damaged mitochondria can trigger autophagy, a process that attempts to remove dysfunctional cellular components, but this process becomes less efficient with age, further exacerbating metabolic dysfunction [3].

Another important aspect of metabolic aging is the dysregulation of lipid metabolism. As people age, there is an increase in the storage of visceral fat, which is metabolically active and contributes to the secretion of pro-inflammatory cytokines. This leads to an imbalance in lipid homeostasis, increasing the risk of cardiovascular disease and other metabolic disorders. The dysfunction of adipose tissue, particularly the expansion of adipose tissue in visceral areas, is often associated with insulin resistance, a major factor in metabolic decline during aging [4].

The mechanistic target of rapamycin (mTOR) pathway has emerged as a crucial player in the regulation of aging and metabolism. mTOR controls cell growth, protein synthesis, and metabolism in response to nutrients and stress signals. Inhibition of the mTOR pathway has been shown to extend lifespan and improve metabolic health in animal models. This has led to increased interest in mTOR inhibitors, such as rapamycin, as potential therapeutic agents for counteracting the metabolic dysfunction associated with aging. However, the long-term effects and safety of mTOR inhibitors in humans remain areas of active research [5].

Caloric restriction (CR) is another widely studied approach for modulating metabolic dysfunction and promoting longevity. CR has been shown to reduce the risk of age-related diseases and extend lifespan in various organisms [6]. The beneficial effects of CR are thought to be mediated by several mechanisms, including reduced oxidative stress, improved mitochondrial function, and enhanced autophagy. While CR is not always feasible or sustainable for humans, its effects on metabolism highlight the importance of energy balance in aging. Researchers are exploring pharmacological agents that can mimic the beneficial effects of CR, such as sirtuin activators and AMP-activated protein kinase (AMPK) modulators, which could offer therapeutic strategies for managing age-related metabolic dysfunction without the need for drastic dietary changes [7].

In addition to these strategies, recent advances in regenerative medicine and gene therapy offer promising avenues for addressing metabolic dysfunction in aging [8]. For example, gene therapies aimed at restoring mitochondrial function or enhancing cellular repair mechanisms could help mitigate the effects of metabolic decline. Additionally, the use of stem cells to regenerate damaged tissues may offer new ways to treat metabolic disorders and promote healthy aging [9].

The role of the gut microbiome in metabolic health has also garnered significant attention in recent years. The gut microbiota influences various aspects of metabolism, including nutrient absorption, inflammation, and immune function. Dysbiosis, or an imbalance in the gut microbiome, has been linked to several metabolic disorders, including obesity, type 2 diabetes, and cardiovascular disease. Interventions aimed at restoring a healthy microbiome, such as the use of probiotics or prebiotics, may offer new therapeutic targets for improving metabolic function during aging [10].

Conclusion

In conclusion, metabolic dysfunction is a central feature of aging and contributes to the development of a variety of age-related diseases. Understanding the mechanisms that drive these changes, including insulin resistance, mitochondrial dysfunction, inflammation, and lipid metabolism disturbances, is essential for developing effective therapeutic strategies. Approaches such as mTOR inhibition, caloric restriction mimetics, gene therapy, and microbiome modulation show promise in combating age-related metabolic decline. As research continues, these strategies could offer new opportunities for enhancing healthspan and delaying the onset of age-related diseases.

References

  1. Natarajan V, Chawla R, Mah T, et al. Mitochondrial dysfunction in age-related metabolic disorders. Proteomics. 2020;20(5-6):1800404.

    2. Indexed at, Google Scholar, Cross Ref

  2. Amorim JA, Coppotelli G, Rolo AP, et al. Mitochondrial and metabolic dysfunction in ageing and age-related diseases. Nat Rev Endocrinol. 2022;18(4):243-58.

    3. Indexed at, Google Scholar, Cross Ref

  3. Uranga RM, Bruce-Keller AJ, Morrison CD, et al. Intersection between metabolic dysfunction, high fat diet consumption, and brain aging. J Neurochem. 2010;114(2):344-61.

    4. Indexed at, Google Scholar, Cross Ref

  4. Haas RH. Mitochondrial dysfunction in aging and diseases of aging. Biol. 2019;8(2):48.

    5. Indexed at, Google Scholar, Cross Ref

  5. López-Gambero AJ, Sanjuan C, Serrano-Castro PJ, et al. The biomedical uses of inositols: A nutraceutical approach to metabolic dysfunction in aging and neurodegenerative diseases. Biomedicines. 2020;8(9):295.

    6. Indexed at, Google Scholar, Cross Ref

  6. Jazwinski SM, Jiang JC, Kim S. Adaptation to metabolic dysfunction during aging: Making the best of a bad situation. Exp Gerontol. 2018;107:87-90.

    7. Indexed at, Google Scholar, Cross Ref

  7. Bhatti JS, Kumar S, Vijayan M, et al. Therapeutic strategies for mitochondrial dysfunction and oxidative stress in age-related metabolic disorders. Progress in molecular biology and translational science. 2017;146:13-46.

    8. Indexed at, Google Scholar, Cross Ref

  8. Corona G, Bianchini S, Sforza A, et al. Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men. Hormones. 2015;14(4):569-78.

    9. Indexed at, Google Scholar, Cross Ref

  9. Stout MB, Justice JN, Nicklas BJ, et al. Physiological aging: links among adipose tissue dysfunction, diabetes, and frailty. Physiol. 2017;32(1):9-19.

    10. Indexed at, Google Scholar, Cross Ref

  10. Barzilai N, Huffman DM, Muzumdar RH, et al. The critical role of metabolic pathways in aging. Diabetes. 2012;61(6):1315-22.

    11. Google Scholar

Get the App